141 related articles for article (PubMed ID: 10391680)
1. Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis.
Kirchhoff S; Hauser H
Oncogene; 1999 Jun; 18(25):3725-36. PubMed ID: 10391680
[TBL] [Abstract][Full Text] [Related]
2. IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo.
Kröger A; Dallügge A; Kirchhoff S; Hauser H
Oncogene; 2003 Feb; 22(7):1045-56. PubMed ID: 12592391
[TBL] [Abstract][Full Text] [Related]
3. Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.
Tan RS; Taniguchi T; Harada H
Cancer Res; 1996 May; 56(10):2417-21. PubMed ID: 8625321
[TBL] [Abstract][Full Text] [Related]
4. Activation of multiple growth regulatory genes following inducible expression of IRF-1 or IRF/RelA fusion proteins.
Nguyen H; Lin R; Hiscott J
Oncogene; 1997 Sep; 15(12):1425-35. PubMed ID: 9333018
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.
Lee AH; Hong JH; Seo YS
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836
[TBL] [Abstract][Full Text] [Related]
6. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.
Chelbi-alix MK; Bobé P; Benoit G; Canova A; Pine R
Oncogene; 2003 Dec; 22(57):9121-30. PubMed ID: 14668793
[TBL] [Abstract][Full Text] [Related]
7. Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice.
Kröger A; Ortmann D; Krohne TU; Mohr L; Blum HE; Hauser H; Geissler M
Cancer Res; 2001 Mar; 61(6):2609-17. PubMed ID: 11289138
[TBL] [Abstract][Full Text] [Related]
8. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
Hoover RR; Gerlach MJ; Koh EY; Daley GQ
Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of interferon regulatory factor-1 in oncogene-transformed mouse fibroblasts.
Contente S; Attard FA; Yeh TJ; Buchhagen DL; Friedman RM
J Interferon Cytokine Res; 2003 Nov; 23(11):639-47. PubMed ID: 14651778
[TBL] [Abstract][Full Text] [Related]
10. [Identification and analysis of IRF-1 binding protein].
Kondo T
Hokkaido Igaku Zasshi; 1996 Jul; 71(4):509-16. PubMed ID: 8809574
[TBL] [Abstract][Full Text] [Related]
11. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR.
Kirchhoff S; Koromilas AE; Schaper F; Grashoff M; Sonenberg N; Hauser H
Oncogene; 1995 Aug; 11(3):439-45. PubMed ID: 7543195
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
13. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
[TBL] [Abstract][Full Text] [Related]
14. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
[TBL] [Abstract][Full Text] [Related]
15. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes.
Tamura T; Ishihara M; Lamphier MS; Tanaka N; Oishi I; Aizawa S; Matsuyama T; Mak TW; Taki S; Taniguchi T
Nature; 1995 Aug; 376(6541):596-9. PubMed ID: 7637809
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the signal transduction pathway leading to human immunodeficiency virus-1-induced interferon regulatory factor-1 upregulation.
Sgarbanti M; Marsili G; Remoli AL; Ridolfi B; Stellacci E; Borsetti A; Ensoli B; Battistini A
Ann N Y Acad Sci; 2004 Dec; 1030():187-95. PubMed ID: 15659797
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
18. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
19. Differential function of STAT5 isoforms in head and neck cancer growth control.
Leong PL; Xi S; Drenning SD; Dyer KF; Wentzel AL; Lerner EC; Smithgall TE; Grandis JR
Oncogene; 2002 Apr; 21(18):2846-53. PubMed ID: 11973644
[TBL] [Abstract][Full Text] [Related]
20. STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells.
de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L
Mol Cell Biol Res Commun; 2000 May; 3(5):299-305. PubMed ID: 10964754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
